Multicenter, observational and retrospective study to evaluate the clinical management of patients newly diagnosed with locally advanced or metastatic non-small cell lung cancer (NSCLC), and to characterize and describe how the procedure is carried out.
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: MERCK SHARP & DOHME DE ESPAÑA SA
- Execution start: 04/02/2020
- End of execution: 30/12/2020
- IP: JAVIER VALDIVIA BAUTISTA
